{"id":"W2523786227","doi":"10.1182/blood.v116.21.1954.1954","title":"Pooled Safety Analysis From Phase (Ph) 1 and 2 Studies of Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (MM)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Tolerability; Proteasome inhibitor; Neutropenia; Bortezomib; Medicine; Adverse effect; Internal medicine; Pharmacology; Multiple myeloma; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01457269,0.001208525,0.002364229,0.001678679,0.0003853752,0.001228627,0.0005345352,0.001022475,0.002447395],"category_scores_gemma":[0.01049812,0.0005216398,0.00499086,0.001250844,0.0004209683,0.0006630705,0.0007708869,0.001127565,0.0003070942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007870031,"about_ca_system_score_gemma":0.0009789948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004368682,"about_ca_topic_score_gemma":0.0009290198,"domain_scores_codex":[0.9938344,0.003906819,0.0006916007,0.0006074252,0.000751785,0.0002079007],"domain_scores_gemma":[0.9913284,0.003670538,0.00309596,0.0006102899,0.0008332434,0.0004615372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5666482,0.003034376,0.1112677,0.00587463,0.1252362,0.000443655,0.0003484841,0.005235299,0.03536473,0.000257194,0.004655399,0.141634],"study_design_scores_gemma":[0.1870926,0.2116791,0.4323423,0.000573045,0.1329314,0.00187902,0.0002199145,0.004073665,0.01323918,0.0008426831,0.01493597,0.0001911419],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9482786,0.03377779,0.003532453,0.0004634496,0.0001432303,0.002817882,0.007781646,0.0001971816,0.003007702],"genre_scores_gemma":[0.988117,0.002953013,0.001318617,0.000421776,0.000190783,0.0008788694,0.005611497,0.0000274343,0.0004810324],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01457269,"threshold_uncertainty_score":0.07706869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01912431446018829,"score_gpt":0.3009066052993577,"score_spread":0.2817822908391694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}